P2X7 receptor activation in rat brain cultured astrocytes increases the biosynthetic release of cysteinyl leukotrienes

International Journal of Immunopathology and Pharmacology

Volumn 18, Issue 3, 2005, Pages 417-430

  Ballerini, Patrizia ^a   Ciccarelli, R ^a   Caciagli, F ^a   Rathbone, M P ^b   Werstiuk, E S ^b   Traversa, U ^c   Buccella, S ^a   Giuliani, P ^a   Jiang, S ^b   Nargi, E ^a   Visini, D ^a   Santavenere, C ^a   Di Iorio, P ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Astrocytes; Cysteinyl leukotriene release; P2X7

Indexed keywords

3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; ABC TRANSPORTER; ADENOSINE TRIPHOSPHATE DERIVATIVE; ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN; CALCIMYCIN; CALCIUM ION; CALCIUM IONOPHORE; EGTAZIC ACID; LIPOXYGENASE; MESSENGER RNA; PEPTIDOLEUKOTRIENE; PROTEIN INHIBITOR; PURINE P2X7 RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; PURINERGIC RECEPTOR STIMULATING AGENT; VERLUKAST; 2',3' DIALDEHYDE ATP; 2',3'-DIALDEHYDE ATP; 3' O (4 BENZOYL)BENZOYLADENOSINE 5' TRIPHOSPHATE; 3'-O-(4-BENZOYL)BENZOYLADENOSINE 5'-TRIPHOSPHATE; 5-LIPOXYGENASE-ACTIVATING PROTEIN; ADENOSINE TRIPHOSPHATE; CARRIER PROTEIN; CHELATING AGENT; CYSTEINE; CYSTEINYL-LEUKOTRIENE; DRUG DERIVATIVE; INDOLE DERIVATIVE; IONOPHORE; LEUKOTRIENE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LIPOXYGENASE INHIBITOR; MEMBRANE PROTEIN; PROPIONIC ACID DERIVATIVE; PURINE P2 RECEPTOR; QUINOLINE DERIVATIVE;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BIOSYNTHESIS; BRAIN CELL; CALCIUM TRANSPORT; CONTROLLED STUDY; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; UPREGULATION; AFFINITY LABELING; ANIMAL; BRAIN; BRAIN CORTEX; CELL CULTURE; CHEMISTRY; CYTOLOGY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; SECRETION;

ADENOSINE TRIPHOSPHATE; AFFINITY LABELS; ANIMALS; ASTROCYTES; BRAIN; CALCIMYCIN; CARRIER PROTEINS; CELLS, CULTURED; CEREBRAL CORTEX; CHELATING AGENTS; CYSTEINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EGTAZIC ACID; INDOLES; IONOPHORES; LEUKOTRIENE ANTAGONISTS; LEUKOTRIENES; LIPOXYGENASE INHIBITORS; MEMBRANE PROTEINS; PROPIONATES; QUINOLINES; RATS; RECEPTORS, PURINERGIC P2; RNA, MESSENGER; UP-REGULATION;

EID: 27444433860     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200501800303     Document Type: Article

References (58)

1. Abramovitz M., E. Wong, M.E. Cox, C.D. Richardson, C. Li and P.J. Vickers. 1993. 5-lipoxygenase-activating protein stimulates the utilization of arachidonic acid by 5-lipoxygenase. Eur. J. Biochem. 215:105.
2. Alric L., E. Pinelli, G. Carrera, J.P. Vinel, M. Beraud, M. Duffaut, J.P. Pascal and B. Pipy. 1996. Involvement of calcium in macrophage leukotriene release during experimental cirrhosis. Hepatology 23:614.
3. Ballerini P., P. Di Iorio, R. Ciccarelli, F. Caciagli, A. Poli, A. Beraudi, S. Buccella, M. D'Auro, E. Nargi, D. Visini and U. Traversa. 2004. P2Y1 and cysteinyl-leukotriene receptors mediate purine and cysteinyl-leukotriene co-release in primary cultures of rat microglia. Int. J. Immunopathol. Pharmacol. 18:233.
4. 1 receptors. Glia 32 (S):91
5. Ballerini P., P. Di Iorio, R. Ciccarelli, E. Nargi, I. D'Alimente, U. Traversa, M.P. Rathbone and F. Caciagli. 2002. Glial cells express multiple ATP binding cassette proteins which are involved in ATP release. Neuroreport. 13:1789.
6. 7) receptors regulate intracellular calcium and purine release. Neuroreport 7:2533.
7. Biswal S.S., K. Datta and J.P. Kehrer. 2001. Association between bcl-x(L) and 5-lipoxygenase activating protein (FLAP) levels in IL-3-dependent FL5.12 cells. Toxicology 160:97.
8. Brambilla R., G. Burnstock, A. Bonazzi, S. Ceruti, F. Cattabeni and M.P. Abbracchio. 1999. Cyclooxygenase-2 mediates P2Y receptor-induced reactive astrogliosis. Br. J. Pharmacol. 126:563.
9. Brash A.R. 1999. Lipoxygenases: occurrence, functions, catalysis, and acquisition of substrate. J. Biol. Chem. 274:23679.
10. Chen Z.S., S. Aoki, M. Komatsu, K. Ueda, T. Sumizawa, T. Furukawa, H. Okumura, X.Q. Ren, M.G. Belinsky, K. Lee, G.D. Kruh, M. Kobayashi and S. Akiyama. 2001. Reversal of drug resistance mediated by multidrug resistance protein (MRP) 1 by dual effects of agosterol A on MRP1 function. Int. J. Cancer. 93:107.
11. Ciccarelli R., P. Ballerini, G. Sabatino, M.P. Rathbone, M. D'Onofrio, F. Caciagli and P. Di Iorio. 2001. Involvement of astrocytes in purine-mediated reparative processes in the brain. Int. J. Dev. Neurosci. 19:395.
12. 1 receptors and mitogen-activated protein kinase pathway. Eur. J. Neurosci. 20:1514.
13. Ciccarelli R., P. Di Iorio, P. Giuliani, I. D'Alimonte, P. Ballerini, F. Caciagli and M.P. Rathbone. 1999. Rat cultured astrocytes release guanine-based purines in basal conditions and after hypoxia/hypoglycemia. Glia 25:93.
14. Ciceri P., M. Rabuffetti, A. Monopoli and S. Nicosia. 2001. Production of leukotrienes in a model of focal cerebral ischaemia in the rat. Br. J. Pharmacol 133:1323.
15. 7 receptors. J. Biol. Chem. 278:30732.
16. Columba-Cabezas S., B. Serafini, E. Ambrosini and F. Aloisi. 2003. Lymphoid chemokines CCL19 and CCL21 are expressed in the central nervous system during experimental autoimmune encephalomyelitis: implications for the maintenance of chronic neuroinflammation. Brain Pathol. 13:38.
17. Croitoru-Lamoury J., G.J. Guillemin, F.D. Boussin, B. Mognetti, L.I. Gigout, A. Cheret, B. Vaslin, R. Le Grand, B.J. Brew and D. Dormont. 2003. Expression of chemokines and their receptors in human and simian astrocytes: evidence for a central role of TNF alpha and IFN gamma in CXCR4 and CCR5 modulation. Glia 41:354.
18. Di Iorio P., P. Ballerini, F. Caciagli and R. Ciccarelli. 1988. Purinoceptor-mediated modulation of purine and neurotransmitter release from nervous tissue. Pharmacol. Res. 37:169.
19. Dixon R.A., R.E. Diehl, E. Opas, E. Rands, P.J. Vickers, J.F. Evans, J.W. Gillard and D.K. Miller. 1990. Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis. Nature 343:282.
20. Erb L., K.D. Lustig, A.H. Ahmed, F.A. Gonzalez and G.A. Weisman. 1990 Covalent incorporation of 3′-O-(4-benzoyl)benzoyl-ATP into a P2 purinoceptor in transformed mouse fibroblasts. J. Biol. Chem. 265:7424.
21. Ferrari D., M. Munerati, L. Melchiorrri, S. Hanau, F. Di Virgilio and O.R. Baricordi. 1994. Responses to extracellular ATP of lymphoblastoid cell lines from Duchenne muscolar dystrophy patients. Am. J. Physiol. 267:866.
22. Fiebich B.L., T.J. Hofer, K. Lieb, M. Huell, R.D. Butcher, G. Schumann, K. Schulze-Osthoff and J. Bauer. 1999. The non-steroidal anti-inflammatory drug tepoxalin inhibits interleukin-6 and alpha1-anti-chymotrypsin synthesis in astrocytes by preventing degradation of IkappaB-alpha. Neuropharmacology. 38:1325.
23. 7 nucleotide receptor activation enhances IFN gamma-induced type II nitric oxide synthase activity in BV-2 microglial cells. J. Neurochem. 87:344.
24. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260:3440.
25. Hendeles L., D. Davison, E. Harman and J.M. Sherman. 1999. The effect of Cys LT1 receptor blockade on airway responses to allergen. Pharmacotherapy. 19:1243.
26. Jobin C. and J. Gauthier. 1997. Differential effects of cell density on 5-lipoxygenase (5-LO), five-lipoxygenase-activating protein (FLAP) and interleukin-1 beta (IL-1 beta) expression in human neutrophils. Inflammation. 21:235.
27. Khakh B.S., G. Burnstock, C. Kennedy, B.F. King, R.A. North, P. Seguela, M. Voigt and P.P. Humphrey. 2001. International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. Pharmacol. Rev. 53:107.
28. 7 receptor in immune cells of the brain and periphery. J. Biol. Chem. 276:23262.
29. 7 receptors in neurodegeneration. Eur. J. Pharmacol. 447:261.
30. Lee S.J., K. Drabik, N.J. Van Wagoner, S. Lee, C. Choi, Y. Dong and E.N. Benveniste. 2000. ICAM-1-induced expression of proinflammatory cytokines in astrocytes: involvement of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways. J. Immunol. 165:4658.
31. Leker R.R. and E. Shohami 2002. Cerebral ischemia and trauma-different etiologies yet similar mechanisms: neuroprotective opportunities. Brain Res. Brain Res. Rev. 39:55.
32. Levison S.W. and K.D. McCarthy. 1991. Characterization and partial purification of AIM: a plasma protein that induces rat cerebral type 2 astroglia from bipotential glial progenitors. J. Neurochem. 57:782.
33. Luo S.F., H.L. Tsao, R. Ong, J.T. Hsieh and C.M. Yang. 1995 Inhibitory effect of phorbol ester on bradykinin-induced phosphoinositide hydrolysis and calcium mobilization in cultured canine tracheal smooth muscle cells. Cell Signal. 7:571.
34. Mancini J.A., M. Abramovitz, M.E. Cox, E. Wong, S. Charleson, H. Perrier, Z. Wang, P. Prasit and P.J. Vickers. 1993 5-lipoxygenase-activating protein is an arachidonate binding protein. FEBS Lett. 318:277.
35. Mena M.A., S. de Bernardo, M.J. Casarejos, S. Canals and E. Rodriguez-Martin. 2002. The role of astroglia on the survival of dopamine neurons. Mol. Neurobiol. 25:245.
36. Murgia M., S. Hananu, P. Pizzo, M. Rippa and F. Di Virgilio. 1993. Oxidized ATP. An irreversible inhibitor of the macrophage purinergic P2Z receptor. J. Biol. Chem. 268:8199.
37. Nieber K., D. Eschke and A. Brand. 1999. Brain hypoxia: effects of ATP and adenosine. Prog. Brain Res. 120:287.
38. 7-like receptor activation in astrocytes increases chemokine monocyte chemoattractant protein-1 expression via mitogen-activated proteinkinase. J. Neurosci. 21:7135.
39. 7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer's disease. J. Biol. Chem. 278:13309.
40. Pouliot M., P.P. McDonald, P. Borgeat and S.R. McColl. 1994. Granulocyte/macrophage colony-stimulating factor stimulates the expression of the 5-lipoxygenase-activating protein (FLAP) in human neutrophils. J. Exp. Med. 179:1225.
41. Qu T., T. Uz and H. Manev. 2000. Inflammatory 5-LOX mRNA and protein are increased in brain of aging rats. Neurobiol Aging. 21:647.
42. 7 receptor modulation of beta-amyloid- and LPS-induced cytokine secretion from human macrophages and microglia. J. Neuroimmunol. 147:56.
43. Rathbone M.P., P.J. Middlemiss, J.W. Gysbers, C. Andrew, M.A. Herman, J.K. Reed, R. Ciccarelli, P. Di Iorio and F. Caciagli. 1999. Trophic effects of purines in neurons and glial cells. Prog. Neurobiol. 59:663.
44. Reddy K.V., K.J. Serio, C.R. Hodulik and T.D. Bigby. 2003. 5-lipoxygenase-activating protein gene expression. Key role of CCAAT/enhancer-binding proteins (C/EBP) in constitutive and tumor necrosis factor (TNF) alpha-induced expression in THP-1 cells. J. Biol. Chem. 278:13810.
45. Rosenberger T.A., N.B. Villacreses, J.T. Hovda, F. Bosetti, G. Weerasinghe, R.N. Wine, G.J. Harry and S.I. Rapoport. 2004. Rat brain arachidonic acid metabolism is increased by a 6-day intracerebral ventricular infusion of bacterial lipopolysaccharide. J. Neurochem. 88:1168.
46. Rudolfi K.A. 1994. In Adenosine and adenine nucleotides as regulators of cellular function. J.W. Phillips, ed. Bocaraton, FL:CRC, p. 423.
47. Sheng J.G., K. Ito, R.D. Skinner, R.E. Mrak, C.R. Rovnaghi, L.J. Van Eldik and W.S. Griffin 1996 In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis. Neurobiol. Aging 17:761.
48. Shigemoto-Mogami Y., S. Koizumi, M. Tsuda, K. Ohsawa, S. Kohsaka and K. Inoue. 2001. Mechanisms underlying extracellular ATP-evoked interleukin-6 release in mouse microglial cell line, MG-5. J. Neurochem. 78:1339.
49. Simmet T., W. Luck, M. Winking, W.K. Delank and B.A. Peskar. 1990. Identification and characterization of cysteinyl-leukotriene formation in tissue slices from human intracranial tumors: evidence for their biosynthesis under in vivo conditions. J. Neurochem. 54:2091.
50. Simmet T. and B. Tippler. 1991. On the relation between cerebral cysteinyl-leukotriene formation and epileptic seizures. Brain Res. 540:283.
51. Stanimirovic D. and K. Satoh. 2000. Inflammatory mediators of cerebral endothelium: a role in ischemic brain inflammation. Brain Pathol. 10:113.
52. 7 nucleotide receptor mediation of membrane pore formation and superoxide generation in human promyelocytes and neutrophils. J. Immunol. 166:6754.
53. Suryadevara R., S. Holter, K. Borgmann, R. Persidsky, C. Labenz-Zink, Y. Persidsky, H.E. Gendelman, L. Wu and A. Ghorpade. 2003. Regulation of tissue inhibitor of metalloproteinase-1 by astrocytes: links to HIV-1 dementia. Glia 44:47.
54. 2+-ATPase. Proc. Natl. Acad. Sci. 87:2466.
55. Vickers P.J. 1995. 5-Lipoxygenase-activating protein (FLAP). J. Lipid Mediat. Cell Signal. 12:185.
56. 7 receptor. J. Physiol. 519:335.
57. Westcott J.Y., S.E. Wenzel and S.C. Dreskin. 1996. Arachidonate-induced eicosanoid synthesis in RBL-2H3 cells: stimulation with antigen or A23187 induces prolonged activation of 5-lipoxygenase. Biochim. Biophys. Acta 1303:74
58. Xu J., M. Chalimoniuk, Y. Shu, A. Simonyi, A.Y. Sun, F.A. Gonzalez, G.A. Weisman, W.G. Wood and G.Y.Sun. 2003. Prostaglandin E2 production in astrocytes: regulation by cytokines, extracellular ATP, and oxidative agents. Prostaglandins Leukot. Essent. Fatty Acids 69:437.